Home > Category > Signaling Pathways > Cytoskeletal Signaling > Integrin > Anti-Human CD49d Monoclonal Antibody(Natalizumab)

那他珠单抗

ChemLeader 98+%
Catalog No:CLA1024 CAS No.:189261-10-7 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days ¥2000.00 Visible after login
- +
5 mg 3-5days ¥7500.00 Visible after login
- +
10 mg 3-5days ¥12000.00 Visible after login
- +
50 mg 3-5days ¥28000.00 Visible after login
- +
100 mg 3-5days ¥45600.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Anti-Human CD49d Monoclonal Antibody(Natalizumab)
CAS189261-10-7
Storage conditionStore the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Product details

Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays